Henlez Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 1

Employees

  • Latest Deal Type
  • Later Stage VC
  • (Upcoming)

  • Investors
  • 3

Henlez General Information

Description

Developer of a biotechnology platform designed to support dermatology drug development through topical enzyme-based therapies. The company offers a proprietary topical GEP enzyme technology platform for dermatological applications, enabling pharmaceutical companies and healthcare providers to develop targeted skin treatment products and advance dermatology innovation.

Contact Information

Website
www.henlez.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Fruebjergvej 3
  • 2100 Copenhagen
  • Denmark
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • Fruebjergvej 3
  • 2100 Copenhagen
  • Denmark

Henlez Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Henlez Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC Upcoming Pre-Clinical Trials
5. Later Stage VC 11-Dec-2024 Completed Generating Revenue
4. Secondary Transaction - Private 23-Sep-2024 Completed Pre-Clinical Trials
3. Early Stage VC 24-Oct-2022 Completed Pre-Clinical Trials
2. Accelerator/Incubator 25-Nov-2021 $7.71K $76.2K Completed Startup
1. Accelerator/Incubator 01-Jan-2020 $68.5K $68.5K Completed Startup
To view Henlez’s complete valuation and funding history, request access »

Henlez Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
Series 1 18,518 $56.78 $56.78 1x $56.78 23.47%
To view Henlez’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Henlez Patents

Henlez Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2021257618-A1 Compositions and methods for treating hair follicle-linked conditions Active 15-Apr-2020
AU-2021257618-B2 Compositions and methods for treating hair follicle-linked conditions Active 15-Apr-2020
CA-3180191-A1 Compositions and methods for treating hair follicle-linked conditions Pending 15-Apr-2020
EP-4135755-A1 Compositions and methods for treating hair follicle-linked conditions Active 15-Apr-2020
EP-4135755-B1 Compositions and methods for treating hair follicle-linked conditions Active 15-Apr-2020 A61K8/66
To view Henlez’s complete patent history, request access »

Henlez Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Henlez Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Eir Ventures Venture Capital Minority
Nordic Mentor Network For Entrepreneurship Accelerator/Incubator
InnoFounder Accelerator/Incubator Minority
To view Henlez’s complete investors history, request access »

Henlez FAQs

  • When was Henlez founded?

    Henlez was founded in 2019.

  • Where is Henlez headquartered?

    Henlez is headquartered in Copenhagen, Denmark.

  • What is the size of Henlez?

    Henlez has 1 total employees.

  • What industry is Henlez in?

    Henlez’s primary industry is Biotechnology.

  • Is Henlez a private or public company?

    Henlez is a Private company.

  • What is Henlez’s current revenue?

    The current revenue for Henlez is .

  • How much funding has Henlez raised over time?

    Henlez has raised $2.48M.

  • Who are Henlez’s investors?

    Eir Ventures, Nordic Mentor Network For Entrepreneurship, and InnoFounder have invested in Henlez.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process